RWD and RWE are reshaping the design of clinical trials, making them smarter, faster, and more efficient. Read more here: ...
Bioxytran, Inc. (OTCQB: BIXT) today announced positive clinical results from its recently completed Phase 2 randomized, double-blind, placebo-controlled, dose-optimization ...
A groundbreaking phase 2 clinical trial has unveiled promising advancements in the treatment landscape for non-small cell lung cancer (NSCLC), ...
As darkness retreats and flotation tanks gain popularity, a UCSD professor examines how “sensory deprivation” experiments ...
Medicus Pharma Ltd. (NASDAQ: MDCX) ("Medicus" or the "Company"), a precision guided biotech/life sciences company focused on advancing the clinical development ...
News Medical on MSN
Novel neuroprotective drug improves recovery after acute ischemic stroke
Stroke patients treated intravenously with loberamisal, a novel neuroprotective medication, daily for 10 days and starting within 48 hours of stroke symptoms, had better recovery than patients who ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results